AU4536693A - Chimeric anti-CEA antibody - Google Patents
Chimeric anti-CEA antibodyInfo
- Publication number
- AU4536693A AU4536693A AU45366/93A AU4536693A AU4536693A AU 4536693 A AU4536693 A AU 4536693A AU 45366/93 A AU45366/93 A AU 45366/93A AU 4536693 A AU4536693 A AU 4536693A AU 4536693 A AU4536693 A AU 4536693A
- Authority
- AU
- Australia
- Prior art keywords
- sequence
- seq
- constant domain
- human
- none
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3007—Carcino-embryonic Antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90407492A | 1992-06-15 | 1992-06-15 | |
US904074 | 1992-06-15 | ||
PCT/US1993/005709 WO1993025237A1 (fr) | 1992-06-15 | 1993-06-15 | Anticorps chimerique anti antigene carcino-embryonnaire |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4536693A true AU4536693A (en) | 1994-01-04 |
Family
ID=25418496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU45366/93A Abandoned AU4536693A (en) | 1992-06-15 | 1993-06-15 | Chimeric anti-CEA antibody |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0606430A1 (fr) |
JP (1) | JPH06509947A (fr) |
AU (1) | AU4536693A (fr) |
CA (1) | CA2115346A1 (fr) |
WO (1) | WO1993025237A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5605793A (en) * | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
US6117679A (en) * | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US6165793A (en) * | 1996-03-25 | 2000-12-26 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US20060257890A1 (en) | 1996-05-20 | 2006-11-16 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
US6309883B1 (en) | 1994-02-17 | 2001-10-30 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
US6335160B1 (en) | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
US6153410A (en) * | 1997-03-25 | 2000-11-28 | California Institute Of Technology | Recombination of polynucleotide sequences using random or defined primers |
GB9712512D0 (en) | 1997-06-16 | 1997-08-20 | Bioinvent Int Ab | A method for in vitro molecular evolution of protein function |
US6958213B2 (en) | 2000-12-12 | 2005-10-25 | Alligator Bioscience Ab | Method for in vitro molecular evolution of protein function |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4921690A (en) * | 1986-12-29 | 1990-05-01 | City Of Hope | Method of enhancing the biodistribution of antibody for localization in lesions |
US5081235A (en) * | 1989-07-26 | 1992-01-14 | City Of Hope | Chimeric anti-cea antibody |
-
1993
- 1993-06-15 EP EP93915354A patent/EP0606430A1/fr not_active Withdrawn
- 1993-06-15 AU AU45366/93A patent/AU4536693A/en not_active Abandoned
- 1993-06-15 WO PCT/US1993/005709 patent/WO1993025237A1/fr not_active Application Discontinuation
- 1993-06-15 CA CA002115346A patent/CA2115346A1/fr not_active Abandoned
- 1993-06-15 JP JP6501788A patent/JPH06509947A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2115346A1 (fr) | 1993-12-23 |
EP0606430A1 (fr) | 1994-07-20 |
WO1993025237A1 (fr) | 1993-12-23 |
JPH06509947A (ja) | 1994-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU606320B2 (en) | Modular assembly of antibody genes, antibodies prepared thereby and use | |
AU632462B2 (en) | Modular assembly of antibody genes, antibodies prepared thereby and use | |
AU656633B2 (en) | Chimeric antibody with specificity to human tumor antigen | |
Fell et al. | Homologous recombination in hybridoma cells: heavy chain chimeric antibody produced by gene targeting. | |
US5721108A (en) | Chimeric antibody with specificity to human B cell surface antigen | |
CA2070659C (fr) | Preparation d'anticorps | |
US6652852B1 (en) | Chimeric antibody with specificity to human B cell surface antigen | |
US5472693A (en) | Family of anti-carcinoembryonic antigen chimeric antibodies | |
EP2412808B1 (fr) | Anticorps bispécifique du type lh | |
KR102687014B1 (ko) | 인간화된 항-pd-1 항체 및 이의 용도 | |
KR20160005143A (ko) | 항-인간 cd52 면역글루불린 | |
AU6344790A (en) | Chimeric anti-cea antibody | |
CN110698562A (zh) | 抗人msln单克隆抗体 | |
AU4536693A (en) | Chimeric anti-CEA antibody | |
KR20170066327A (ko) | 항-세라마이드 항체 | |
AU652923B2 (en) | Specific binding agents | |
KR102014400B1 (ko) | Ceacam6에 특이적으로 결합하는 항-ceacam6 키메릭 항원 수용체 | |
KR20230049463A (ko) | Cd138을 인식하는 재조합 단백질 및 이를 유효성분으로 포함하는 암의 치료용 약학적 조성물 | |
AU606653C (en) | Chimeric antibody with specificity to human B cell surface antigen |